T. Rowe Price Associates’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40K | Sell |
35,210
-7,654
| -18% | -$8.7K | ﹤0.01% | 3022 |
|
2025
Q1 | $50K | Sell |
42,864
-3,526,135
| -99% | -$4.11M | ﹤0.01% | 2932 |
|
2024
Q4 | $21.8M | Sell |
3,568,999
-445,260
| -11% | -$2.72M | ﹤0.01% | 972 |
|
2024
Q3 | $66.4M | Sell |
4,014,259
-60,832
| -1% | -$1.01M | 0.01% | 671 |
|
2024
Q2 | $28M | Buy |
4,075,091
+187,068
| +5% | +$1.29M | ﹤0.01% | 868 |
|
2024
Q1 | $37.5M | Buy |
3,888,023
+628,001
| +19% | +$6.06M | ﹤0.01% | 798 |
|
2023
Q4 | $27.1M | Buy |
3,260,022
+17,307
| +0.5% | +$144K | ﹤0.01% | 868 |
|
2023
Q3 | $27.1M | Buy |
3,242,715
+11,845
| +0.4% | +$98.9K | ﹤0.01% | 843 |
|
2023
Q2 | $29.8M | Buy |
3,230,870
+1,109,995
| +52% | +$10.2M | ﹤0.01% | 833 |
|
2023
Q1 | $29.1M | Sell |
2,120,875
-85,532
| -4% | -$1.18M | ﹤0.01% | 824 |
|
2022
Q4 | $37.5M | Sell |
2,206,407
-11,359
| -0.5% | -$193K | 0.01% | 738 |
|
2022
Q3 | $50.4M | Sell |
2,217,766
-405,107
| -15% | -$9.21M | 0.01% | 641 |
|
2022
Q2 | $47.3M | Buy |
2,622,873
+376,832
| +17% | +$6.79M | 0.01% | 892 |
|
2022
Q1 | $60M | Sell |
2,246,041
-125,234
| -5% | -$3.35M | 0.01% | 907 |
|
2021
Q4 | $69.5M | Buy |
2,371,275
+13,811
| +0.6% | +$405K | 0.01% | 886 |
|
2021
Q3 | $155M | Buy |
2,357,464
+371,393
| +19% | +$24.4M | 0.01% | 631 |
|
2021
Q2 | $165M | Buy |
1,986,071
+189,760
| +11% | +$15.8M | 0.02% | 621 |
|
2021
Q1 | $138M | Buy |
1,796,311
+467,527
| +35% | +$35.9M | 0.01% | 671 |
|
2020
Q4 | $117M | Buy |
1,328,784
+460,573
| +53% | +$40.7M | 0.01% | 674 |
|
2020
Q3 | $64.1M | Sell |
868,211
-39,017
| -4% | -$2.88M | 0.01% | 791 |
|
2020
Q2 | $66.2M | Buy |
907,228
+88,926
| +11% | +$6.49M | 0.01% | 757 |
|
2020
Q1 | $45.9M | Sell |
818,302
-99,219
| -11% | -$5.57M | 0.01% | 811 |
|
2019
Q4 | $35M | Buy |
917,521
+102,242
| +13% | +$3.9M | ﹤0.01% | 1021 |
|
2019
Q3 | $14.5M | Buy |
+815,279
| New | +$14.5M | ﹤0.01% | 1232 |
|